User contributions for Jerneja Nimac
From Wiki FKKT
Jump to navigationJump to search
10 May 2021
- 20:3220:32, 10 May 2021 diff hist +1 Proizvodnja škrlatnega indigoidnega barvila iz triptofana v bakteriji Escherichia coli →Proizvodnja škrlatnega barvila v E. coli in barvanje tkanin current
- 20:3220:32, 10 May 2021 diff hist 0 Proizvodnja škrlatnega indigoidnega barvila iz triptofana v bakteriji Escherichia coli →Vzpostavitev poti – od triptofana do 6-bromoindola
- 18:2918:29, 10 May 2021 diff hist +13 Proizvodnja škrlatnega indigoidnega barvila iz triptofana v bakteriji Escherichia coli No edit summary
- 18:2218:22, 10 May 2021 diff hist +4 Proizvodnja škrlatnega indigoidnega barvila iz triptofana v bakteriji Escherichia coli No edit summary
- 18:2018:20, 10 May 2021 diff hist +397 MBT seminarji 2021 No edit summary
- 18:0118:01, 10 May 2021 diff hist +5,921 N Proizvodnja škrlatnega indigoidnega barvila iz triptofana v bakteriji Escherichia coli New page: Škrlat je starodavno barvilo, ki so ga v preteklosti pridobivali iz prekurzorja ekstrahiranega iz mediteranskih morskih polžkov iz družine ''Muricidae''<sup>1,2</sup>. Glavna komponenta...
8 April 2021
- 14:1614:16, 8 April 2021 diff hist +116 Značilnosti cepiva proizvajalca Pfizer / BioNTech (mRNA) No edit summary current
- 14:1514:15, 8 April 2021 diff hist +11,517 N Cepivo proizvajalca Pfizer / BioNTech - optimizacija zaporedja molekule mRNA New page: Podjetji Pfizer in BioNTech sta se septembra 2020 odločili, da objavita celotno zaporedje molekule mRNA, ki jo vsebuje njihovo cepivo Comirnaty<sup>1</sup> in nosi zapis za celoten protei... current
31 March 2021
- 08:2508:25, 31 March 2021 diff hist +10 Značilnosti cepiva proizvajalca Pfizer / BioNTech (mRNA) No edit summary
30 March 2021
- 19:4619:46, 30 March 2021 diff hist +4 Značilnosti cepiva proizvajalca Pfizer / BioNTech (mRNA) No edit summary
- 19:4419:44, 30 March 2021 diff hist +2 Protikovidna cepiva No edit summary
- 19:4319:43, 30 March 2021 diff hist +71 N Značilnosti cepiva proizvajalca Pfizer/BioNTech (mRNA) Značilnosti cepiva proizvajalca Pfizer/BioNTech (mRNA) moved to Značilnosti cepiva proizvajalca Pfizer / BioNTech (mRNA) current
- 19:4319:43, 30 March 2021 diff hist 0 m Značilnosti cepiva proizvajalca Pfizer / BioNTech (mRNA) Značilnosti cepiva proizvajalca Pfizer/BioNTech (mRNA) moved to Značilnosti cepiva proizvajalca Pfizer / BioNTech (mRNA)
- 19:4019:40, 30 March 2021 diff hist +2 Protikovidna cepiva No edit summary
- 19:3719:37, 30 March 2021 diff hist +5,099 N Značilnosti cepiva proizvajalca Pfizer / BioNTech (mRNA) New page: Cepivo pod lastniškim imenom Comirnaty (BNT162b2, nelastniško: Tozinameran) sta v sklopu projekta 'Svetlobna hitrost' razvili farmacevtski podjetji BioNTech in Pfizer<sup>1-3</sup>. Cepi...
14 May 2020
- 08:0908:09, 14 May 2020 diff hist +4 Seminarji SB 2019/20 No edit summary
- 08:0508:05, 14 May 2020 diff hist +161 Seminarji SB 2019/20 No edit summary
13 May 2020
- 09:2109:21, 13 May 2020 diff hist +257 Načrtovanje mikrobnih konzorcijev z določenimi družbenimi interakcijami →Pomen sinteznih konzorcijev current
- 09:1909:19, 13 May 2020 diff hist 0 Načrtovanje mikrobnih konzorcijev z določenimi družbenimi interakcijami →Prostorska dinamika treh simetričnih ekosistemov
10 May 2020
- 11:4711:47, 10 May 2020 diff hist +8 Načrtovanje mikrobnih konzorcijev z določenimi družbenimi interakcijami No edit summary
- 11:4511:45, 10 May 2020 diff hist −1 Seminarji SB 2019/20 No edit summary
- 11:4211:42, 10 May 2020 diff hist +204 Seminarji SB 2019/20 No edit summary
- 11:4011:40, 10 May 2020 diff hist +12,481 N Načrtovanje mikrobnih konzorcijev z določenimi družbenimi interakcijami New page: '''''Povzeto po članku:''''' [https://www.nature.com/articles/s41589-018-0091-7 Kong, W., Meldgin, D. R., Collins, J. J. in Lu, T. Designing microbial consortia with defined social intera...
3 May 2020
- 10:2210:22, 3 May 2020 diff hist +138 ALiVE – analiza živih celic z vezikularnim izvozom →Ideja current
- 10:1710:17, 3 May 2020 diff hist +77 ALiVE – analiza živih celic z vezikularnim izvozom →Rezultati
- 09:4209:42, 3 May 2020 diff hist 0 ALiVE – analiza živih celic z vezikularnim izvozom →ALiVE kot diagnostično orodje za beta celično terapijo'
- 09:4009:40, 3 May 2020 diff hist +159 Seminarji SB 2019/20 No edit summary
- 09:3709:37, 3 May 2020 diff hist +9,802 N ALiVE – analiza živih celic z vezikularnim izvozom New page: Spletna stran projekta ALiVE, iGEM 2019, https://2019.igem.org/Team:Munich Skupina iz Municha je na tekmovanju iGEM leta 2019 razvila študentski projekt z naslovom ALiVE. Cilj projekta j...
10 April 2020
- 13:1013:10, 10 April 2020 diff hist −86 Seminarji SB 2019/20 No edit summary
8 April 2020
- 21:2221:22, 8 April 2020 diff hist +1 Seminarji SB 2019/20 No edit summary
- 21:2121:21, 8 April 2020 diff hist +41 Seminarji SB 2019/20 No edit summary
31 March 2020
- 07:0207:02, 31 March 2020 diff hist +11 Seminarji SB 2019/20 No edit summary
10 March 2020
- 06:4906:49, 10 March 2020 diff hist +15 Seminarji SB 2019/20 No edit summary
7 March 2020
- 19:4719:47, 7 March 2020 diff hist +451 Seminarji SB 2019/20 No edit summary
16 March 2018
- 10:2910:29, 16 March 2018 diff hist +25 Molekularna biologija virusov No edit summary
15 March 2018
- 17:3617:36, 15 March 2018 diff hist +33 Molekularna biologija virusov No edit summary
1 December 2017
- 20:5620:56, 1 December 2017 diff hist +1,839 BIO2 Povzetki seminarjev 2017 →Biokemija- Povzetki seminarjev 2017/2018
24 November 2017
- 21:3921:39, 24 November 2017 diff hist +125 BIO2 Seminar 2017 →Seznam seminarjev
- 21:3521:35, 24 November 2017 diff hist +1,520 BIO2 Povzetki seminarjev 2017 →Biokemija- Povzetki seminarjev 2017/2018
12 November 2017
14 March 2017
- 16:2816:28, 14 March 2017 diff hist +1,326 TBK2017 Povzetki seminarjev →Ana Scott: Naslov seminarja
4 March 2017
- 13:2013:20, 4 March 2017 diff hist +130 TBK2017-seminar →Seznam seminarjev
